To guide your patients through their turning points and triumphs, you’ll need a clear map—one that’s always accessible, available to your patients and their families, and complete with comprehensive information regarding the best possible routes for care.
Find exhaustive answers based on your patient’s unique position. If your patient is living with prostate cancer, chart a path forward with ProstateNow™, revolutionary germline testing that predicts prognoses and therapeutic responses. For all solid tumors, OncoTarget®—the largest FDA-cleared genomic profiling panel, analyzing over 500 genes—can provide unmatched insights into well-suited therapies based on certain mutations and biomarkers.
Actionable. Affordable. And quick, with turnaround times of just 6 to 10 days. We reimagine the possibilities of diagnostic testing because every provider and every patient deserves pathology tools that fight as hard as they do.